Hereditary transthyretin-related amyloidosis (hATTR) with polyneuropathy is a rare, progressive and fatal disease that has been challenging for neurologists to diagnose and manage, until now. Advances in genetic testing have yielded the development of a new generation of more efficient screenings that make early, accurate, and rapid diagnosis more accessible.
Dr Marzouka discusses the fact that patients cannot shop around for a better deal when going to the emergency department and are almost never presented with the cost of care prior to receiving it.
Benjamin Frush MD, a resident in internal medicine-pediatrics at Vanderbilt University Medical Center in Nashville, argues in favor of a role that physicians can play in integrating religion into their clinical practice. Rob Poole MB, FRCPsych, contends that physicians should never incorporate a religious element into clinical practice.
Patients and their families are advocating for their right to access the latest medical research papers to help find potential treatments and understand health conditions.
Attempting to engage on an intellectual level about the heady concept of brain death while in the throes of bereavement can often lead to mistrust and confusion.
Key opinion leaders weigh in given recent findings that increased use of therapeutic coma in status epilepticus may not be linked with improved outcomes.
The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.
Interventional stroke treatment continues to rapidly evolve as health care providers implement new protocols to ensure more rapid, successful treatment.
Technology called Brain Network Activation allows health care professionals to evaluate brain network function after traumatic brain injury and during recovery.
The RiverSpring at Night program accommodates the altered sleep cycles of Alzheimer’s dementia patients with a drug-free approach to nighttime activities and comprehensive care.